Deregulation of CLDN6 expression and distribution has been associated with epithelial cancer progression [9] in non-small-cell lung, ovarian, cervical, and breast carcinomas [10,11,12,13], but in the latter, its function as a tumor-promoting or tumor suppressor gene has been recognized [14,15]. Here, CLDN6 is linked to breast carcinoma.